Compare PLX & YCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PLX | YCY |
|---|---|---|
| Founded | 1993 | 2025 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 182.9M | 150.0M |
| IPO Year | 1996 | 2025 |
| Metric | PLX | YCY |
|---|---|---|
| Price | $2.76 | $10.32 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 767.5K | 18.5K |
| Earning Date | 08-12-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.27 | N/A |
| Revenue | ★ $52,744,000.00 | N/A |
| Revenue This Year | $55.77 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $10.30 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.60 | $9.90 |
| 52 Week High | $3.19 | $10.33 |
| Indicator | PLX | YCY |
|---|---|---|
| Relative Strength Index (RSI) | 57.87 | 54.40 |
| Support Level | $2.59 | $9.95 |
| Resistance Level | $2.85 | N/A |
| Average True Range (ATR) | 0.09 | 0.02 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 76.14 | 50.00 |
Protalix BioTherapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, production, and commercialization of therapeutics for rare diseases with important unmet needs. ProCellEx, a proprietary plant cell-based protein expression system, represents a new method for developing recombinant proteins in an industrial-scale manner. corporate includes the development of treatments for rare and orphan diseases. The Company operates as a single operating segment in Israel.
AA Mission Acquisition Corp II is a blank check company formed for the purpose of effectuating a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses or entities.